P
Purple Biotech Ltd
TASE:PPBT
Purple Biotech Ltd
TASE:PPBT
Price:
1
ILS
Market Closed
Market Cap:
₪17.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Purple Biotech Ltd
Effect of Foreign Exchange Rates
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Purple Biotech Ltd
Effect of Foreign Exchange Rates Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Effect of Foreign Exchange Rates | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Purple Biotech Ltd
TASE:PPBT
|
Effect of Foreign Exchange Rates
$7k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Effect of Foreign Exchange Rates
$21m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Sol Gel Technologies Ltd
NASDAQ:SLGL
|
Effect of Foreign Exchange Rates
-$188k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-80%
|
CAGR 10-Years
N/A
|
|
|
PolyPid Ltd
NASDAQ:PYPD
|
Effect of Foreign Exchange Rates
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Effect of Foreign Exchange Rates
$95k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Effect of Foreign Exchange Rates
₪13k
|
CAGR 3-Years
-68%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-20%
|
|
No Stocks Found
Purple Biotech Ltd
Glance View
Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
PPBT
Intrinsic Value
1
ILS
Fairly Valued
P
See Also
What is Purple Biotech Ltd's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
7k
USD
7k
USD
Based on the financial report for Dec 31, 2025, Purple Biotech Ltd's Effect of Foreign Exchange Rates amounts to 7k USD.
What is Purple Biotech Ltd's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 5Y
-35%
-35%
